Detecting moderator effects using subgroup analyses (Q34184426)

31 July 2017

Detecting moderator effects using subgroup analyses (English)

1 reference

31 July 2017

Rui Wang

1

1 reference

PubMed ID

21562742

31 July 2017

James H Ware

series ordinal

2

1 reference

31 July 2017

1 April 2013

1 reference

31 July 2017

1 reference

31 July 2017

14

1 reference

31 July 2017

2

1 reference

31 July 2017

111-120

1 reference

https://scigraph.springernature.com/pub.10.1007/s11121-011-0221-x

31 July 2017

0 references

cites work

Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Odds ratios for mediation analysis for a dichotomous outcome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Analysis of randomized comparative clinical trial data for personalized treatment selections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Moderators of outcome in a brief family-centered intervention for preventing early problem behavior.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Causal inference in randomized experiments with mediational processes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

The challenge of subgroup analyses--reporting without distorting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Feasibility of treating prehypertension with an angiotensin-receptor blocker

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Calcium plus vitamin D supplementation and the risk of colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Calcium plus vitamin D supplementation and the risk of fractures

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Number needed to treat: a descriptor for weighing therapeutic options

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Classification and regression tree analysis in public health: methodological review and comparison with logistic regression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Statistical significance for genomewide studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Mediators and moderators of treatment effects in randomized clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Fallibility in estimating direct effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Subgroup analysis and other (mis)uses of baseline data in clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Calculating the number needed to treat for trials where the outcome is time to an event

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

The number needed to treat: a clinically useful measure of treatment effect

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

The choice of treatment for cancer patients based on covariate information.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Assessing apparent treatment--covariate interactions in randomized clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Non-parametric analysis of treatment-covariate interaction in the presence of censoring.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Identifiability and exchangeability for direct and indirect effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Patterns of treatment effects in subsets of patients in clinical trials

5 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Testing for qualitative interactions between treatment effects and patient subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

A stagewise rejective multiple test procedure based on a modified Bonferroni test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

A general approach to causal mediation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Penalised regression splines: theory and application to medical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

A deficiency of the odds ratio as a measure of effect size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Test for qualitative interaction of clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Misunderstandings about the effects of race and sex on physicians' referrals for cardiac catheterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Multiple Hypothesis Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

An improved Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Evaluating markers for selecting a patient's treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

The benefits of booster interventions: evidence from a family-focused prevention program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Bias formulas for sensitivity analysis for direct and indirect effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Statistics in medicine--reporting of subgroup analyses in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

Detecting qualitative interactions in clinical trials: an extension of range test.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Interaction between prognostic factors and treatment.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193873

Best-practice recommendations for estimating interaction effects using moderated multiple regression

28 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11121-011-0221-X

A multivariate test of interaction for use in clinical trials

21 January 2018

1 reference

12 December 2020

Tests against qualitative interaction: exact critical values and robust tests

1 reference

12 December 2020

On the practice of dichotomization of quantitative variables

1 reference

12 December 2020

Reconsidering the odds ratio as a measure of 2x2 association in a population

1 reference

12 December 2020

Confidence interval estimation of interaction

1 reference

12 December 2020

A comparison of the power of two tests for qualitative interactions

1 reference

12 December 2020

Confidence intervals for measures of interaction

1 reference

12 December 2020

Moderators of treatment outcomes: clinical, research, and policy importance

1 reference

12 December 2020

Test for additive interaction in proportional hazards models

1 reference

12 December 2020

Four types of effect modification: a classification based on directed acyclic graphs

1 reference

12 December 2020

Toward non-parametric and clinically meaningful moderators and mediators

1 reference

12 December 2020

10.1007/S11121-011-0221-X

Identifiers

DOI

1 reference

PubMed ID

21562742

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference

PubMed ID

21562742